Author

D. Corvino

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

A. Kumar· 1 shared B. Barber· 1 shared B. G. M. Hughes· 1 shared C. Edwards· 1 shared C. Engwerda· 1 shared D. Andrew· 1 shared D. Pathirana· 1 shared D. Rommel· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Kumar

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Type I interferon drives a cellular state inert to TCR-stimulation and could impede effective T-cell differentiation in cancer

D. Corvino, M. Batstone, B. G. M. Hughes, T. Kempchen, S. S. Ng, N. Salim, F. Schneppenheim, D. Rommel, A. Kumar, S. Pearson, J. Madore, L. T. Koufariotis, L. M. Steinheuer, D. Pathirana, K. Thurley, , T. Bald

The paper identifies a subset of CD8+ TILs in HPV-HNSCC enriched for interferon-stimulated genes that are transcriptionally inert to TCR stimulation and may hinder T-cell differentiation.

bioRxiv · Mar 28, 2024Immunology

STING activation promotes autologous type I interferon-dependent development of type 1 regulatory T cells during malaria

Y. Wang, F. Rivera, C. Edwards, T. Frame, J. A. Engel, L. Bukali, J. Na, S. Ng, D. Corvino, M. Montes de Oca, P. Bunn, M. Soon, D. Andrew, J. Loughland, F. Amante, , C. Engwerda

This study shows STING activation promotes Tr1 cell development during malaria by enhancing IFNB gene transcription and modulates this pathway with ruxolitinib.

bioRxiv · Sep 4, 2022Immunology